Christian Bocobo
Physical Medicine & Rehabilitation · Daly City, CANPI 1447212428
Payments from drug & device makers
Across 219 payments — averaging $20.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$589
- Merck$276
- Novo Nordisk$258
- Boston Scientific$251
- Scilex Pharmaceuticals Inc.$216
- plus $1K from 28 others
What the payments were for
- Food & beverage$4,466100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 68 | $1,379 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 30 | $589 |
| Merck | 14 | $276 |
| Novo Nordisk | 15 | $258 |
| Boston Scientific | 8 | $251 |
| Scilex Pharmaceuticals Inc. | 10 | $216 |
| Arbor Pharmaceuticals, Inc. | 20 | $207 |
| Merz North America, Inc. | 1 | $150 |
| E.r. Squibb & Sons, L.L.C. | 3 | $137 |
| Amgen(2 entities) | 7 | $122 |
| Biogen | 4 | $82 |
| Chiesi USA, Inc. | 5 | $77 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $59 |
| Assertio Therapeutics, Inc. | 3 | $58 |
| Boehringer Ingelheim | 3 | $53 |
| Lilly USA, LLC | 2 | $48 |
| Lexicon Pharmaceuticals, Inc. | 2 | $47 |
| Abbott | 2 | $43 |
| Medicomp Inc | 2 | $41 |
| Dexcom, Inc. | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $38 |
| Astellas Pharma US Inc | 1 | $29 |
| AstraZeneca | 2 | $28 |
| Medtronic | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Orthofix Medical, Inc. | 1 | $26 |
| Forte Bio-pharma LLC | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Nabriva Therapeutics, PLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$150
How this compares
$4,466 in reported general payments places this provider in the 85th percentile of 830 physical medicine & rehabilitation providers in California.
See all physical medicine & rehabilitation providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 22 | $107 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Daly City
- Ziyad AyyoubParamount$1.8M
- John ShenFontana$1.3M
- Andrew SkalskySan Diego$463K
- Nanette JoyceSacramento$237K
- Mary OatesSanta Maria$158K
- Jeryl WiensFresno$125K
- Pratik GandhiAnaheim$122K
- Ronald SchillingLong Beach$113K
- Kevin BarretteSan Francisco$84K
- Jeffrey ChenSan Diego$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.